Estado actual en el mundo | 13 ABR 15

Enfermedad por virus Chikungunya

Propagación mundial de una enfermedad transmitida por mosquitos. Una revisión para el médico práctico, ¿qué hay que saber?
Autor/a: Scott C. Weaver, Marc Lecuit Fuente: New England Journal of Medicine 2015;372:1231-9. Chikungunya Virus and the Global Spread of a Mosquito-Borne Disease
INDICE:  1.  | 2. Referencias
Referencias

1. Ross RW. The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic. J Hyg
(Lond) 1956; 54: 177-91.
2. Voss JE, Vaney MC, Duquerroy S, et al. Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature 2010; 468: 709-12.
3. Zhang R, Hryc CF, Cong Y, et al. 4.4 Å cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus. EMBO J 2011; 30: 3854-63.
4. Volk SM, Chen R, Tsetsarkin KA, et al. Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates. J Virol 2010; 84:6497-504.
5. Powers AM, Brault AC, Tesh RB, Weaver SC. Re-emergence of Chikungunya and O’nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J Gen
Virol 2000; 81: 471-9.
6. Carey DE. Chikungunya and dengue: a case of mistaken identity? J Hist Med Allied Sci 1971; 26: 243-62.
7. Chretien JP, Anyamba A, Bedno SA, et al. Drought-associated chikungunya emergence along coastal East Africa. Am J Trop Med Hyg 2007; 76: 405-7.
8. Weaver SC, Osorio JE, Livengood JA, Chen R, Stinchcomb DT. Chikungunya virus and prospects for a vaccine. Expert Rev Vaccines 2012; 11: 1087-101.
9. Tsetsarkin KA, Chen R, Yun R, et al. Multi-peaked adaptive landscape for chikungunya virus evolution predicts continued fitness optimization in Aedes albopictus mosquitoes. Nat Commun 2014; 5: 4084.
10. Schuffenecker I, Iteman I, Michault A, et al. Genome microevolution of chikungunya viruses causing the Indian Ocean
outbreak. PLoS Med 2006; 3(7): e263.
11. Tsetsarkin KA, Weaver SC. Sequential adaptive mutations enhance efficient vector switching by Chikungunya virus and its epidemic emergence. PLoS Path g 2011; 7(12): e1002412.
12. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog 2007; 3(12): e201.
13. Vazeille M, Moutailler S, Coudrier D, et al. Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in
the mosquito, Aedes albopictus. PLoS One 2007; 2(11): e1168.
14. Tsetsarkin KA, Chen R, Leal G, et al. Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes. Proc Natl Acad Sci U S A 2011; 108: 7872-7.
15. Lanciotti RS, Kosoy OL, Laven JJ, et al. Chikungunya virus in US travelers returning from India, 2006. Emerg Infect Dis 2007; 13: 764-7.
16. Leparc-Goffart I, Nougairede A, Cassadou S, Prat C, de Lamballerie X. Chikungunya in the Americas. Lancet 2014; 383: 514.
17. Nhan TX, Claverie A, Roche C, et al. Chikungunya virus imported into French polynesia, 2014. Emerg Infect Dis 2014; 20: 1773-4.
18. Jupp PG, Kemp A. What is the potential for future outbreaks of chikungunya, dengue and yellow fever in southern Africa? S Afr Med J 1996; 86: 35-7.
19. Demanou M, Antonio-Nkondjio C, Ngapana E, et al. Chikungunya outbreak in a rural area of Western Cameroon in 2006: a retrospective serological and entomological survey. BMC Res Notes 2010;3: 128.
20. Weinbren MP. The occurrence of Chikungunya virus in Uganda. II. In man on the Entebbe peninsula. Trans R Soc Trop Med Hyg 1958; 52: 258-9.
21. Diallo M, Thonnon J, Traore-Lamizana M, Fontenille D. Vectors of Chikungunya virus in Senegal: current data and transmission cycles. Am J Trop Med Hyg 1999; 60: 281-6.
22. Paupy C, Ollomo B, Kamgang B, et al.Comparative role of Aedes albopictus and Aedes aegypti in the emergence of dengue and chikungunya in central Africa. Vector Borne Zoonotic Dis 2010; 10: 259-66.
23. Sang RC, Ahmed O, Faye O, et al. Entomologic investigations of a chikungunya virus epidemic in the Union of the Comoros, 2005. Am J Trop Med Hyg 2008; 78: 77-82.
24. Panning M, Grywna K, van Esbroeck M, Emmerich P, Drosten C. Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006. Emerg Infect Dis 2008; 14: 416-22.
25. Stoddard ST, Forshey BM, Morrison AC, et al. House-to-house human movement drives dengue virus transmission. Proc Natl Acad Sci U S A 2013; 110: 994-9.
26. Leisnham PT, LaDeau SL, Juliano SA. Spatial and temporal habitat segregation of mosquitoes in urban Florida. PLoS One 2014; 9(3): e91655.
27. Rudolph KE, Lessler J, Moloney RM, Kmush B, Cummings DA. Incubation periods of mosquito-borne viral infections:a systematic review. Am J Trop Med Hyg 2014; 90: 882-91.
28. Suhrbier A, Jaffar-Bandjee MC, Gasque P. Arthritogenic alphaviruses —an overview. Nat Rev Rheumatol 2012; 8:420-9.
29. Brouard C, Bernillon P, Quatresous I, et al. Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007. Transfusion 2008; 48: 1333-41.
30. Thiberville SD, Boisson V, Gaudart J, Simon F, Flahault A, de Lamballerie X. Chikungunya fever: a clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean. PLoS Negl Trop Dis 2013; 7(1): e2004.
31. Staikowsky F, Talarmin F, Grivard P, et al. Prospective study of Chikungunya virus acute infection in the Island of La Réunion during the 2005-2006 outbreak. PLoS One 2009; 4(10): e7603.
32. Capeding MR, Chua MN, Hadinegoro SR, et al. Dengue and other common causes of acute febrile illness in Asia: an active surveillance study in children. PLoS Negl Trop Dis 2013; 7(7): e2331.
33. Javelle E, Tiong TH, Leparc-Goffart I, Savini H, Simon F. Inflammation of the external ear in acute chikungunya infection: experience from the outbreak in Johor Bahru, Malaysia, 2008. J Clin Virol 2014; 59: 270-3.
34. Gérardin P, Barau G, Michault A, et al. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion. PLoS Med 2008; 5(3): e60.
35. Delang L, Segura Guerrero N, Tas A, et al. Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral. J Antimicrob Chemother 2014;69: 2770-84.
36. Briolant S, Garin D, Scaramozzino N, Jouan A, Crance JM. In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds:synergistic effect of interferonalpha and ribavirin combination. Antiviral Res 2004; 61: 111-7.
37. Schilte C, Staikowsky F, Couderc T, et al. Chikungunya virus-associated longterm arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis 2013; 7(3): e2137.
38. Ganu MA, Ganu AS. Post-chikungunya chronic arthritis — our experience with DMARDs over two year follow up. J Assoc Physicians India 2011; 59: 83-6.
39. Schwartz O, Albert ML. Biology and pathogenesis of chikungunya virus. Nat Rev Microbiol 2010; 8: 491-500.
40. Teo TH, Lum FM, Lee WW, Ng LF. Mouse models for Chikungunya virus: deciphering immune mechanisms responsible for disease and pathology. Immunol Res 2012; 53: 136-47.
41. Labadie K, Larcher T, Joubert C, et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 2010; 120:894-906.
42. Couderc T, Chrétien F, Schilte C, et al. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog 2008; 4(2): e29.
43. Schilte C, Couderc T, Chretien F, et al. Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J Exp Med 2010; 207: 429-42.
44. Couderc T, Khandoudi N, Grandadam M, et al. Prophylaxis and therapy for Chikungunya virus infection. J Infect Dis 2009; 200: 516-23.
45. Eisen L, Beaty BJ, Morrison AC, Scott TW. ProactiveVector control strategies and improved monitoring and evaluation practices for dengue prevention. J Med Entomol 2009; 46: 1245-55.
46. Phuc HK, Andreasen MH, Burton RS, et al. Late-acting dominant lethal genetic systems and mosquito control. BMC Biol 2007; 5: 11.
47. Moreira LA, Iturbe-Ormaetxe I, Jef- 26, 2015 1239 Chikungunya Virus fery JA, et al. A Wolbachia symbiont in Aedes aegypti limits infection with dengue, Chikungunya, and Plasmodium. Cell 2009; 139: 1268-78.
48. Mousson L, Martin E, Zouache K, Madec Y, Mavingui P, Failloux AB. Wolbachia modulates Chikungunya replication in Aedes albopictus. Mol Ecol 2010; 19:1953-64.
49. vanden Hurk AF, Hall-Mendelin S, Pyke AT, et al. Impact of Wolbachia on infection with chikungunya and yellow fever viruses in the mosquito vector Aedes aegypti. PLoS Negl Trop Dis 2012;
6(11): e1892.
50. Loroño-Pino MA, García-Rejón JE, Machain-Williams C, et al. Towards a Casa Segura: a consumer product study of the effect of insecticide-treated curtains on Aedes aegypti and dengue virus infections in the home. Am J Trop Med Hyg 2013; 89: 385-97.
51. Lum FM, Teo TH, Lee WW, Kam YW, Rénia L, Ng LF. An essential role of antibodies in the control of Chikungunya virus infection. J Immunol 2013; 190: 6295-302.
52. Stapleford KA, Coffey LL, Lay S, et al. Emergence and transmission of arbovirus evolutionary intermediates with epidemic potential. Cell Host Microbe 2014; 15: 706-16.
53. Chang LJ, Dowd KA, Mendoza FH, et al. Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial. Lancet 2014; 384: 2046-52.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2022